Aly Nada

460 total citations
36 papers, 363 citations indexed

About

Aly Nada is a scholar working on Pharmaceutical Science, Pharmacology and Analytical Chemistry. According to data from OpenAlex, Aly Nada has authored 36 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 8 papers in Pharmacology and 5 papers in Analytical Chemistry. Recurrent topics in Aly Nada's work include Drug Solubulity and Delivery Systems (19 papers), Advanced Drug Delivery Systems (13 papers) and Advancements in Transdermal Drug Delivery (6 papers). Aly Nada is often cited by papers focused on Drug Solubulity and Delivery Systems (19 papers), Advanced Drug Delivery Systems (13 papers) and Advancements in Transdermal Drug Delivery (6 papers). Aly Nada collaborates with scholars based in Kuwait, Egypt and United States. Aly Nada's co-authors include M. Etman, Abdel‐Azim Zaghloul, Roland Bodmeier, Ibrahim Khattab, Ragwa M. Farid, Yellela S.R. Krishnaiah, Emad Eldin Hassan, Mohsen A. Hedaya, Eva-Maria Graf and Farzana Bandarkar and has published in prestigious journals such as Journal of Hepatology, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Aly Nada

34 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aly Nada Kuwait 11 236 72 47 38 34 36 363
Vivek Borhade India 7 246 1.0× 49 0.7× 57 1.2× 34 0.9× 42 1.2× 7 361
Raviraj Pillai India 9 260 1.1× 71 1.0× 57 1.2× 47 1.2× 35 1.0× 13 348
Silvia Kocova El-Arini Egypt 12 270 1.1× 106 1.5× 63 1.3× 42 1.1× 48 1.4× 21 433
Pradeep Patil India 9 246 1.0× 56 0.8× 54 1.1× 66 1.7× 27 0.8× 13 367
C. P. Jain India 9 233 1.0× 53 0.7× 62 1.3× 76 2.0× 24 0.7× 26 345
Dhananjay S. Singare India 5 286 1.2× 90 1.3× 65 1.4× 39 1.0× 37 1.1× 8 385
Dhaval A. Shah United States 11 227 1.0× 70 1.0× 66 1.4× 28 0.7× 32 0.9× 17 358
Vilasrao Kadam India 9 327 1.4× 41 0.6× 48 1.0× 46 1.2× 52 1.5× 19 420
Haruki Higashino Japan 9 217 0.9× 76 1.1× 55 1.2× 49 1.3× 18 0.5× 29 335
Guglielmo Zingone Italy 10 191 0.8× 126 1.8× 57 1.2× 46 1.2× 23 0.7× 13 386

Countries citing papers authored by Aly Nada

Since Specialization
Citations

This map shows the geographic impact of Aly Nada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly Nada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly Nada more than expected).

Fields of papers citing papers by Aly Nada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aly Nada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly Nada. The network helps show where Aly Nada may publish in the future.

Co-authorship network of co-authors of Aly Nada

This figure shows the co-authorship network connecting the top 25 collaborators of Aly Nada. A scholar is included among the top collaborators of Aly Nada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aly Nada. Aly Nada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bandarkar, Farzana, Willias Masocha, & Aly Nada. (2021). Pharmacodynamic/pharmacokinetic correlation of optimized ibuprofen nanosuspensions having enhanced anti-inflammatory and antinociceptive activity. Journal of Pharmacy and Pharmacology. 74(3). 387–396. 3 indexed citations
2.
Abdelmonem, Rehab, et al.. (2020). <p>Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System</p>. Drug Design Development and Therapy. Volume 14. 4343–4362. 21 indexed citations
3.
Etman, M., et al.. (2017). In vitro and In vivo Evaluation of Tablets Containing Meloxicam- PEG 6000 Ball-Milled Co-Ground Mixture. Journal of Applied Pharmaceutical Science. 7 indexed citations
4.
Nada, Aly, Abdel‐Azim Zaghloul, Mohsen A. Hedaya, & Ibrahim Khattab. (2014). Development of Novel Formulations to Enhance in Vivo Transdermal Permeation of Tocopherol. Acta Pharmaceutica. 64(3). 299–309. 10 indexed citations
5.
Farid, Ragwa M., et al.. (2013). Formulation and In Vitro Evaluation of Salbutamol Sulphate In Situ Gelling Nasal Inserts. AAPS PharmSciTech. 14(2). 712–718. 47 indexed citations
6.
Nada, Aly. (2012). STABILITY OF VITAMIN E AND VITAMIN E ACETATE CONTAINING COSMETIC PREPARATIONS. 4(3). 1–8. 4 indexed citations
7.
Nada, Aly, Yellela S.R. Krishnaiah, Abdel‐Azim Zaghloul, & Ibrahim Khattab. (2011). In vitro and in vivo Permeation of Vitamin E and Vitamin E Acetate from Cosmetic Formulations. Medical Principles and Practice. 20(6). 509–513. 8 indexed citations
8.
Krishnaiah, Yellela S.R. & Aly Nada. (2011). Enantioselective penetration enhancing effect of carvone on thein vitrotransdermal permeation of nicorandil. Pharmaceutical Development and Technology. 17(5). 574–582. 8 indexed citations
9.
Etman, M., et al.. (2011). In vitro/in vivo Correlation of Fast Release Mephenamic Acid Microspheres in Humans. Medical Principles and Practice. 21(3). 223–227. 4 indexed citations
10.
Etman, M., et al.. (2010). Preparation and evaluation of fast-release mephenamic acid microspheres. Journal of Microencapsulation. 27(7). 640–656. 5 indexed citations
11.
Khattab, Ibrahim, Aly Nada, & Abdel‐Azim Zaghloul. (2010). Physicochemical characterization of gliclazide–macrogol solid dispersion and tablets based on optimized dispersion. Drug Development and Industrial Pharmacy. 36(8). 893–902. 19 indexed citations
12.
Dumas, Emily O., Walid M. Awni, Darrel P. Cohen, et al.. (2010). 747 PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR ABT-072 FOLLOWING SINGLE AND MULTIPLE DOSING IN HEALTHY ADULT VOLUNTEERS. Journal of Hepatology. 52. S291–S291. 2 indexed citations
13.
Nada, Aly, et al.. (2007). Comparative Bioavailability of Norfloxacin Tablets Based on Blood and Urine Data. Medical Principles and Practice. 16(6). 426–431. 4 indexed citations
14.
Nada, Aly, et al.. (2005). Solid State and Dissolution Rate Characterization of Co-Ground Mixtures of Nifedipine and Hydrophilic Carriers. Drug Development and Industrial Pharmacy. 31(8). 719–728. 62 indexed citations
15.
Etman, M. & Aly Nada. (1999). Hydrotropic and cosolvent solubilisation of indomethacin. Acta Pharmaceutica. 49(4). 291–298. 16 indexed citations
16.
Nada, Aly & Eva-Maria Graf. (1998). Evaluation of Vitacel M80K as a new direct compressible vehicle. European Journal of Pharmaceutics and Biopharmaceutics. 46(3). 347–353. 7 indexed citations
17.
Hassan, Emad Eldin, et al.. (1995). Formulation of prolonged release lipid micropellets by emulsion congealing: Optimization of ketoprofen entrapment and release. International Journal of Pharmaceutics. 121(2). 149–155. 17 indexed citations
18.
Elkhodairy, Kadria A., et al.. (1994). Preparation and evaluation of slow-release pan-coated indomethacin granules. Journal of Microencapsulation. 11(3). 271–278. 1 indexed citations
19.
Nada, Aly, et al.. (1992). Preparation andin vitroevaluation of slow release ketoprofen microcapsules formulated into tablets and capsules. Journal of Microencapsulation. 9(3). 365–373. 18 indexed citations
20.
Etman, M., Fatma Ahmed Ismail, & Aly Nada. (1992). Effect of metoclopramide on ketoprofen pharmacokinetics in man. International Journal of Pharmaceutics. 88(1-3). 433–435. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek Borhade Breakdown of academic impact, for papers by Raviraj Pillai Breakdown of academic impact, for papers by Silvia Kocova El-Arini Breakdown of academic impact, for papers by Pradeep Patil Breakdown of academic impact, for papers by C. P. Jain Breakdown of academic impact, for papers by Dhananjay S. Singare Breakdown of academic impact, for papers by Dhaval A. Shah Breakdown of academic impact, for papers by Vilasrao Kadam Breakdown of academic impact, for papers by Haruki Higashino Breakdown of academic impact, for papers by Guglielmo Zingone
Rankless by CCL
2026